Dr. Lieming Ding
MD, HPB Surgery
Director, Pancreatic Surgery
corporate_fareShanghai GoBroad Cancer Institute, Shanghai
Lieming Ding
MD, HPB Surgery
Prof. Lieming Ding is a pancreatic and hepatopancreatobiliary (HPB) surgeon at Shanghai GoBroad Cancer Institute, where he serves as Director of Pancreatic Surgery. He focuses on the assessment and treatment of patients with pancreatic cancer and complex conditions involving the pancreas, liver, gallbladder and biliary tract.
With more than 20 years in HPB surgery, Prof. Ding combines surgical evaluation with interventional and local treatment planning. He has a particular clinical interest in high-intensity focused ultrasound (HIFU) for selected patients with pancreatic cancer, especially where conventional surgery may not be suitable. He works within a multidisciplinary setting where decisions are coordinated with medical oncology, radiology and interventional specialists, which is especially important for pancreatic cancer patients who may need a combination of surgery, systemic therapy, local treatment and supportive care. Treatment recommendations are individualised after a detailed review of imaging, pathology, previous treatment and the patient's overall condition.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Ding, subject to hospital availability and case acceptance.
Why Consider Prof. Lieming Ding?
Prof. Ding is a senior HPB surgeon focused on pancreatic cancer, with a specific interest in HIFU and interventional treatment for complex and advanced disease.
Areas of Specialisation
Pancreatic, hepatobiliary and interventional cancer treatment
Prof. Ding's clinical focus centres on pancreatic cancer surgery and HPB surgery, supported by HIFU and interventional local treatment for selected patients.
Pancreatic & Hepatopancreatobiliary Surgery
Surgical assessment and treatment of complex tumours of the pancreas, liver, gallbladder and biliary tract.
- arrow_rightSurgical evaluation for resectable pancreatic cancer
- arrow_rightTreatment planning for locally advanced disease
- arrow_rightAssessment of recurrent pancreatic tumours
- arrow_rightSurgical assessment of liver and biliary tract tumours
- arrow_rightEvaluation of complex hepatopancreatobiliary conditions
HIFU & Interventional Treatment
Non-invasive and image-guided local treatment options for selected pancreatic and liver tumours.
- arrow_rightNon-invasive local treatment for selected unresectable pancreatic cancer
- arrow_rightSymptom-focused treatment, particularly for cancer-related pain
- arrow_rightUsed as an adjunct alongside systemic therapy or supportive care
- arrow_rightTransarterial chemoembolisation (TACE) for selected liver tumours
- arrow_rightImage-guided interventional treatment planning
Procedures Performed
Surgical, interventional and multidisciplinary cancer services
Prof. Ding offers surgical, HIFU and interventional treatment options for pancreatic and hepatobiliary cancers, planned within a multidisciplinary team.
Pancreatic & HPB Surgery
Complex DiseaseSurgical assessment and treatment for complex pancreatic and hepatopancreatobiliary tumours.
HIFU & Local Interventional Treatment
MultidisciplinaryNon-invasive HIFU and image-guided interventional approaches for selected patients.
Diagnostic & Staging Assessment
DiagnosisDetailed review of imaging, pathology and prior treatment to guide treatment planning.
Second Opinion Consultations
Second OpinionIndependent specialist review for complex pancreatic and hepatobiliary cases.
Education & Training
Prof. Ding completed his medical training in Shanghai and has built a career in hepatopancreatobiliary surgery.
Clinical Experience
Prof. Ding has more than 20 years of experience in hepatopancreatobiliary surgery and currently leads pancreatic surgery at Shanghai GoBroad Cancer Institute.
Languages & International
Prof. Ding consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting Prof. Ding.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Lieming Ding
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Lieming Ding's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Lieming Ding's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Lieming Ding before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Lieming Ding's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Lieming Ding's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Lieming Ding's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Lieming Ding
Prof. Ding specialises in pancreatic surgery and hepatopancreatobiliary (HPB) surgery, with a clinical focus on pancreatic cancer, HIFU and interventional treatment at Shanghai GoBroad Cancer Institute.
Yes. Patients with locally advanced or complex pancreatic cancer may seek an evaluation to determine whether surgery, HIFU, interventional treatment or a combined strategy may be appropriate. Each plan is individualised after a detailed review of imaging, pathology and treatment history.
No. HIFU is generally considered for carefully selected patients, particularly those with unresectable or advanced pancreatic cancer. Suitability depends on imaging findings, tumour location, previous treatment, symptoms and overall health. Expert guidance describes HIFU as a complementary local treatment rather than a replacement for systemic therapy, so specialist evaluation is essential.
International patients can submit their medical records through CancerFax for an initial review and consultation-coordination request. The hospital will confirm appointment availability, required documents and the recommended consultation format, subject to case acceptance.
Patients should provide recent imaging scans and radiology reports, pathology reports, discharge summaries, previous treatment details, recent blood-test results, tumour-marker reports and a brief summary of current symptoms.
Yes. A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history and relevant test results. The final consultation format and availability depend on the doctor's institution.
Connect with Lieming Ding Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.